Scott D. Grimes - Aug 3, 2021 Form 4 Insider Report for Cardlytics, Inc. (CDLX)

Role
Director
Signature
/s/ Kirk Somers, Attorney-in-Fact
Stock symbol
CDLX
Transactions as of
Aug 3, 2021
Transactions value $
-$352,892
Form type
4
Date filed
8/4/2021, 05:02 PM
Previous filing
Aug 3, 2021
Next filing
Aug 19, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CDLX Common Stock Sale -$61.1K -527 -0.22% $115.98* 237K Aug 3, 2021 Direct F1, F2
transaction CDLX Common Stock Sale -$157K -1.35K -0.57% $116.75* 236K Aug 3, 2021 Direct F1, F3
transaction CDLX Common Stock Sale -$47.2K -401 -0.17% $117.76* 235K Aug 3, 2021 Direct F1, F4
transaction CDLX Common Stock Sale -$38.8K -326 -0.14% $118.88* 235K Aug 3, 2021 Direct F1, F5
transaction CDLX Common Stock Sale -$48.6K -400 -0.17% $121.62* 235K Aug 3, 2021 Direct F1, F6
holding CDLX Common Stock 71.1K Aug 3, 2021 See Footnote F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 12, 2020.
F2 The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $115.29 to $116.21, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3), (4), (5) and (6) to this Form 4.
F3 The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $116.29 to $117.23, inclusive.
F4 The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $117.35 to $118.19, inclusive.
F5 The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $118.49 to $119.27, inclusive.
F6 The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $121.50 to $121.74, inclusive.
F7 The reportable securities are held by the 2013 Scott Grimes GRAT UAD.